104 related articles for article (PubMed ID: 8244581)
1. Quantitative and/or qualitative changes in the p21-H-ras post-translational products in regenerating liver and during hepatocarcinogenesis.
Gulbis B; Alexandre K; Galand P
Int J Cancer; 1993 Nov; 55(5):837-40. PubMed ID: 8244581
[TBL] [Abstract][Full Text] [Related]
2. Relative steady-state expression of the different post-translational products of p21-H-ras from normal rat tissues. A 2D-western immunoblot study.
Gulbis B; Galand P
Life Sci; 1994; 54(23):1747-56. PubMed ID: 8196488
[TBL] [Abstract][Full Text] [Related]
3. Normal and abnormal p21 h-ras posttranslational products in human neoplastic and nonneoplastic liver-tissues.
Gulbis B; Alexandre K; Delhaye M; Galand P
Int J Oncol; 1993 Nov; 3(5):1005-9. PubMed ID: 21573466
[TBL] [Abstract][Full Text] [Related]
4. [The role of platelet-derived growth factor and ras P21 in experimental hepatocarcinogenesis].
Zheng J; Ruan Y; Liu B
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):79-82. PubMed ID: 9206209
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal changes in Ha-ras p21 expression through the hepatocyte cell cycle during liver regeneration.
Ng YK; Taborn G; Ahmad I; Radosevich J; Bauer K; Iannaccone P
Dev Biol; 1992 Apr; 150(2):352-62. PubMed ID: 1551479
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of c-Ha-ras oncogene p21 product in pre-neoplastic and neoplastic lesions during hepatocarcinogenesis in rats.
Galand P; Jacobovitz D; Alexandre K
Int J Cancer; 1988 Jan; 41(1):155-61. PubMed ID: 3275589
[TBL] [Abstract][Full Text] [Related]
7. Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.
Watatani M; Perantoni AO; Reed CD; Enomoto T; Wenk ML; Rice JM
Cancer Res; 1989 Mar; 49(5):1103-9. PubMed ID: 2645046
[TBL] [Abstract][Full Text] [Related]
8. Prenylated proteins in regenerating rat liver.
Bruscalupi G; Castellano F; Sacco S; Trentalance A
Biochem Biophys Res Commun; 1994 May; 200(3):1713-20. PubMed ID: 8185630
[TBL] [Abstract][Full Text] [Related]
9. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice.
Ahmad K; Naz RK
Mol Reprod Dev; 1993 Nov; 36(3):297-306. PubMed ID: 8286110
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DHEP).
Richmond RE; Carter JH; Carter HW; Daniel FB; Deangelo AB
Carcinogenesis; 1996 Aug; 17(8):1647-55. PubMed ID: 8761421
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association.
Kaji I; Tatsuta M; Iishi H; Baba M; Inoue A; Kasugai H
Int J Cancer; 2001 Aug; 93(3):441-4. PubMed ID: 11433412
[TBL] [Abstract][Full Text] [Related]
12. Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio.
Garcea R; Daino L; Pascale R; Simile MM; Puddu M; Ruggiu ME; Seddaiu MA; Satta G; Sequenza MJ; Feo F
Carcinogenesis; 1989 Jul; 10(7):1183-92. PubMed ID: 2472229
[TBL] [Abstract][Full Text] [Related]
13. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
Singh J; Hamid R; Reddy BS
Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
[TBL] [Abstract][Full Text] [Related]
14. Geranylgeranyl as well as farnesyl moiety is transferred to Ras p21 overproduced in adrenocortical cells transformed by c-Ha-rasEJ oncogene.
Osman H; Mazet JL; Maume G; Maume BF
Biochem Biophys Res Commun; 1997 Feb; 231(3):789-92. PubMed ID: 9070894
[TBL] [Abstract][Full Text] [Related]
15. [In situ expression of c-myc, N-ras during diethylnitrosamine induced hepatocarcinogenesis].
Zheng J; Wu Z; Ruan Y
Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):309-11. PubMed ID: 8745481
[TBL] [Abstract][Full Text] [Related]
16. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.
Mangues R; Corral T; Kohl NE; Symmans WF; Lu S; Malumbres M; Gibbs JB; Oliff A; Pellicer A
Cancer Res; 1998 Mar; 58(6):1253-9. PubMed ID: 9515813
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
19. Alterations in enzymatic functions in hepatocytes and hepatocellular carcinomas from Ras-transduced livers resemble the effects of insulin.
Pearline RV; Lin YZ; Shen KJ; Brunt EM; Bowling WM; Hafenrichter DG; Kennedy S; Flye MW; Ponder KP
Hepatology; 1996 Oct; 24(4):838-48. PubMed ID: 8855186
[TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice.
Stanley LA; Devereux TR; Foley J; Lord PG; Maronpot RR; Orton TC; Anderson MW
Carcinogenesis; 1992 Dec; 13(12):2427-33. PubMed ID: 1361883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
